This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer

Premium

Reporting on behalf of the SYNCHRONOUS trial group, the University of Heidelberg's Jurgen Weitz and his colleagues present the details of their clinical investigation, in which they aim to assess whether "patients with colon cancer and synchronous unresectable metastases who present without severe symptoms should undergo resection of the primary tumor prior to systemic chemotherapy." In BMC Cancer, the researchers say that eligible patients enrolled in their multicenter, randomized, contro

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.